AKT1 and breast carcinoma: Experiments in the human breast cancer cell line MCF-7, for instance, revealed that ZnR/GPR39 is active in breast cancer cells, and activates MAPK/ERK and PI3K/AKT signaling pathways, resulting in increased proliferation and invasiveness [135].